SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amit Baumel, Stephen M Schueller, Adjusting an Available Online Peer Support Platform in a Program to Supplement the Treatment of Perinatal Depression and Anxiety, JMIR Mental Health, 2016, 3, 1, e11

    CrossRef

  2. 2
    Kohji Hayase, Concerns Involving the Self: What Is It That You Really Worry about, Regret, or Are Anxious about, When Things Do Not Go Right for You?, Psychology, 2016, 07, 04, 627

    CrossRef

  3. 3
    Yingli Zhang, Guoping Huang, Shichang Yang, Wei Liang, Lei Zhang, Changhong Wang, Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials, Asia-Pacific Psychiatry, 2016, 8, 2
  4. 4
    Tero Kujanpää, Jari Jokelainen, Juha Auvinen, Markku Timonen, Generalised anxiety disorder symptoms and utilisation of health care services. A cross-sectional study from the “Northern Finland 1966 Birth Cohort”, Scandinavian Journal of Primary Health Care, 2016, 1

    CrossRef

  5. 5
    Saren H. Seeley, Douglas S. Mennin, Amelia Aldao, Katie A. McLaughlin, Jonathan Rottenberg, David M. Fresco, Impact of Comorbid Depressive Disorders on Subjective and Physiological Responses to Emotion in Generalized Anxiety Disorder, Cognitive Therapy and Research, 2016, 40, 3, 290

    CrossRef

  6. 6
    Mats Dahlin, Gerhard Andersson, Kristoffer Magnusson, Tomas Johansson, Johan Sjögren, Andreas Håkansson, Magnus Pettersson, Åsa Kadowaki, Pim Cuijpers, Per Carlbring, Internet-delivered acceptance-based behaviour therapy for generalized anxiety disorder: A randomized controlled trial, Behaviour Research and Therapy, 2016, 77, 86

    CrossRef

  7. 7
    Laura Orsolini, Carmine Tomasetti, Alessandro Valchera, Felice Iasevoli, Elisabetta Filomena Buonaguro, Federica Vellante, Michele Fornaro, Annastasia Fiengo, Monica Mazza, Roberta Vecchiotti, Giampaolo Perna, Andrea de Bartolomeis, Giovanni Martinotti, Massimo Di Giannantonio, Domenico De Berardis, New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine, Expert Review of Neurotherapeutics, 2016, 16, 5, 483

    CrossRef

  8. 8
    Jonathan W. Reeves, Aaron J. Fisher, Michelle G. Newman, Douglas A. Granger, Sympathetic and hypothalamic-pituitary-adrenal asymmetry in generalized anxiety disorder, Psychophysiology, 2016, 53, 5
  9. 9
    R. W. Booth, D. Sharma, T. I. Leader, The age of anxiety? It depends where you look: changes in STAI trait anxiety, 1970–2010, Social Psychiatry and Psychiatric Epidemiology, 2016, 51, 2, 193

    CrossRef

  10. 10
    Jacob B. Priest, A Bowen Family Systems Model of Generalized Anxiety Disorder and Romantic Relationship Distress, Journal of Marital and Family Therapy, 2015, 41, 3
  11. 11
    Elena Makovac, Frances Meeten, David R. Watson, Aleksandra Herman, Sarah N. Garfinkel, Hugo D. Critchley, Cristina Ottaviani, Alterations in Amygdala-Prefrontal Functional Connectivity Account for Excessive Worry and Autonomic Dysregulation in Generalized Anxiety Disorder, Biological Psychiatry, 2015,

    CrossRef

  12. 12
    Sonya S. Deschênes, Rachel J. Burns, Norbert Schmitz, Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: Findings from the 2012 Canadian Community Health Survey — Mental Health (CCHS-MH), Journal of Psychosomatic Research, 2015, 78, 2, 137

    CrossRef

  13. 13
    Enrique Álvarez, José M Olivares, José L Carrasco, Vanessa López-Gómez, Javier Rejas, Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors, Annals of General Psychiatry, 2015, 14, 1, 2

    CrossRef

  14. 14
    Joseph R. Bardeen, Erin N. Stevens, Charles Brendan Clark, Adrienne C. Lahti, Karen L. Cropsey, Cognitive risk profiles for anxiety disorders in a high-risk population, Psychiatry Research, 2015, 229, 1-2, 572

    CrossRef

  15. 15
    Ella Bekhuis, Lynn Boschloo, Judith G.M. Rosmalen, Robert A. Schoevers, Differential associations of specific depressive and anxiety disorders with somatic symptoms, Journal of Psychosomatic Research, 2015, 78, 2, 116

    CrossRef

  16. 16
    Marie Murcia, Jean-François Chastang, Isabelle Niedhammer, Educational inequalities in major depressive and generalized anxiety disorders: results from the French national SIP study, Social Psychiatry and Psychiatric Epidemiology, 2015, 50, 6, 919

    CrossRef

  17. 17
    Pasquale Roberge, François Normand-Lauzière, Isabelle Raymond, Mireille Luc, Marie-Michèle Tanguay-Bernard, Arnaud Duhoux, Christian Bocti, Louise Fournier, Generalized anxiety disorder in primary care: mental health services use and treatment adequacy, BMC Family Practice, 2015, 16, 1

    CrossRef

  18. 18
    Kevin Hilbert, Daniel S. Pine, Markus Muehlhan, Ulrike Lueken, Susann Steudte-Schmiedgen, Katja Beesdo-Baum, Gray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization, Psychiatry Research: Neuroimaging, 2015, 234, 3, 314

    CrossRef

  19. 19
    Munir Gunes Kutlu, Thomas J. Gould, Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders, Biochemical Pharmacology, 2015, 97, 4, 498

    CrossRef

  20. 20
    Michelle L. Bourgeois, Timothy A. Brown, Perceived Emotion Control Moderates the Relationship Between Neuroticism and Generalized Anxiety Disorder, Cognitive Therapy and Research, 2015, 39, 4, 531

    CrossRef

  21. 21
    José M. Olivares, Enrique Álvarez, José L. Carrasco, María Pérez, Vanessa López-Gómez, Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms, International Clinical Psychopharmacology, 2015, 1

    CrossRef

  22. 22
    Tiago V Sousa, Vânia Viveiros, Maria V Chai, Filipe L Vicente, Gustavo Jesus, Maria J Carnot, Ana C Gordo, Pedro L Ferreira, Reliability and validity of the Portuguese version of the Generalized Anxiety Disorder (GAD-7) scale, Health and Quality of Life Outcomes, 2015, 13, 1

    CrossRef

  23. 23
    Qingsen Ming, Yun Zhang, Jinyao Yi, Xiang Wang, Xiongzhao Zhu, Shuqiao Yao, Serotonin transporter gene polymorphism (5-HTTLPR) L allele interacts with stress to increase anxiety symptoms in Chinese adolescents: a multiwave longitudinal study, BMC Psychiatry, 2015, 15, 1

    CrossRef

  24. 24
    Joseph R. Bardeen, Erin N. Stevens, Sex differences in the indirect effects of cognitive processes on anxiety through emotion regulation difficulties, Personality and Individual Differences, 2015, 81, 180

    CrossRef

  25. 25
    B.F. Dear, L.G. Staples, M.D. Terides, E. Karin, J. Zou, L. Johnston, M. Gandy, V.J. Fogliati, B.M. Wootton, P.M. McEvoy, N. Titov, Transdiagnostic versus disorder-specific and clinician-guided versus self-guided internet-delivered treatment for generalized anxiety disorder and comorbid disorders: A randomized controlled trial, Journal of Anxiety Disorders, 2015, 36, 63

    CrossRef

  26. 26
    Yoshihiko Kadoya, What makes people anxious about life after the age of 65? Evidence from international survey research in Japan, the United States, China, and India, Review of Economics of the Household, 2015,

    CrossRef

  27. 27
    Mei Liao, Fan Yang, Yan Zhang, Zhong He, Ming Song, Tianzi Jiang, Zexuan Li, Shaojia Lu, Weiwei Wu, Linyan Su, Lingjlang Lil, Holistic Perspectives on Trauma, 2015,

    CrossRef

  28. 28
    A. R. Mahableshwarkar, P. L. Jacobsen, Y. Chen, J. S. Simon, A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder, International Journal of Clinical Practice, 2014, 68, 1
  29. 29
    Marina Dyskant Mochcovitch, Rafael Christophe da Rocha Freire, Rafael Ferreira Garcia, Antonio E. Nardi, A systematic review of fMRI studies in generalized anxiety disorder: Evaluating its neural and cognitive basis, Journal of Affective Disorders, 2014, 167, 336

    CrossRef

  30. 30
    Kylie A. Smith, Lisa Iverach, Susan O’Brian, Elaina Kefalianos, Sheena Reilly, Anxiety of children and adolescents who stutter: A review, Journal of Fluency Disorders, 2014, 40, 22

    CrossRef

  31. 31
    Hannah M. Markell, Michelle G. Newman, Robert Gallop, Mary Beth Connolly Gibbons, Karl Rickels, Paul Crits-Christoph, Combined Medication and CBT for Generalized Anxiety Disorder With African American Participants: Reliability and Validity of Assessments and Preliminary Outcomes, Behavior Therapy, 2014, 45, 4, 495

    CrossRef

  32. 32
    Tero Kujanpää, Tero Ylisaukko-Oja, Jari Jokelainen, Miika Linna, Markku Timonen, Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland, Nordic Journal of Psychiatry, 2014, 68, 5, 306

    CrossRef

  33. 33
    Belén Arranz, Duloxetina y trastorno de ansiedad generalizada, una buena asociación, Psiquiatría Biológica, 2014, 21, 1, 3

    CrossRef

  34. 34
    Miraf Mesfin, Kaleab Asres, Workineh Shibeshi, Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in mice, BMC Complementary and Alternative Medicine, 2014, 14, 1, 310

    CrossRef

  35. 35
    Joseph R. Bardeen, Matthew T. Tull, Erin N. Stevens, Kim L. Gratz, Exploring the relationship between positive and negative emotional avoidance and anxiety symptom severity: The moderating role of attentional control, Journal of Behavior Therapy and Experimental Psychiatry, 2014, 45, 3, 415

    CrossRef

  36. 36
    Lauren S. Hallion, Ayelet Meron Ruscio, Amishi P. Jha, Fractionating the role of executive control in control over worry: A preliminary investigation, Behaviour Research and Therapy, 2014, 54, 1

    CrossRef

  37. 37
    Margarita Alegría, Kristine M. Molina, Chih-Nan Chen, NEIGHBORHOOD CHARACTERISTICS AND DIFFERENTIAL RISK FOR DEPRESSIVE AND ANXIETY DISORDERS ACROSS RACIAL/ETHNIC GROUPS IN THE UNITED STATES, Depression and Anxiety, 2014, 31, 1
  38. 38
    Kevin Hilbert, Ulrike Lueken, Katja Beesdo-Baum, Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: A systematic review, Journal of Affective Disorders, 2014, 158, 114

    CrossRef

  39. 39
    Emily L. Gentes, Ayelet Meron Ruscio, Perceptions of Functioning in Worry and Generalized Anxiety Disorder, Cognitive Therapy and Research, 2014, 38, 5, 518

    CrossRef

  40. 40
    Subhashis Banerjee, Yongjun Wang, Laura A. Solt, Kristine Griffett, Melissa Kazantzis, Ariadna Amador, Bahaa M. El-Gendy, Salvador Huitron-Resendiz, Amanda J. Roberts, Youseung Shin, Theodore M. Kamenecka, Thomas P. Burris, Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour, Nature Communications, 2014, 5, 5759

    CrossRef

  41. 41
    Charlotte Both, Georg Kojda, Christian Lange-Asschenfeldt, Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin, Expert Review of Neurotherapeutics, 2014, 14, 1, 29

    CrossRef

  42. 42
    Siegfried Kasper, Celso Iglesias-García, Edward Schweizer, Jacquelyn Wilson, Sarah DuBrava, Rita Prieto, Verne W. Pitman, Lloyd Knapp, Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder, The International Journal of Neuropsychopharmacology, 2014, 17, 05, 685

    CrossRef

  43. 43
    James E. Frampton, Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder, CNS Drugs, 2014, 28, 9, 835

    CrossRef

  44. 44
    Psychometric Properties of the Intolerance of Uncertainty Scale (IUS) in a Lithuanian-speaking population, Journal of European Psychology Students, 2014, 5, 1, 25

    CrossRef

  45. 45
    Joseph R. Bardeen, Thomas A. Fergus, Holly K. Orcutt, The Moderating Role of Experiential Avoidance in the Prospective Relationship Between Anxiety Sensitivity and Anxiety, Cognitive Therapy and Research, 2014, 38, 4, 465

    CrossRef

  46. 46
    Mei Liao, Fan Yang, Yan Zhang, Zhong He, Linyan Su, Lingjiang Li, White matter abnormalities in adolescents with generalized anxiety disorder: a diffusion tensor imaging study, BMC Psychiatry, 2014, 14, 1, 41

    CrossRef

  47. 47
    Julien Chollet, Delphine Saragoussi, Emilie Clay, Clément François, A Clinical Research Practice Datalink Analysis of Antidepressant Treatment Patterns and Health Care Costs in Generalized Anxiety Disorder, Value in Health, 2013, 16, 8, 1133

    CrossRef

  48. 48
    Luís Silva Miguel, Nuno Silva Miguel, Mónica Inês, A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal, Cost Effectiveness and Resource Allocation, 2013, 11, 1, 8

    CrossRef

  49. 49
    Renee D. Goodwin, John R. Seeley, Peter M. Lewinsohn, Childhood respiratory symptoms and mental health problems: The role of intergenerational smoking, Pediatric Pulmonology, 2013, 48, 2
  50. 50
    H. Parmentier, J. García-Campayo, R. Prieto, Comprehensive review of generalized anxiety disorder in primary care in Europe, Current Medical Research and Opinion, 2013, 29, 4, 355

    CrossRef

  51. 51
    David V. Sheehan, Henrik Svedsäter, Julie C. Locklear, Hans Eriksson, Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): Data from a randomized-withdrawal, placebo-controlled maintenance study, Journal of Affective Disorders, 2013, 151, 3, 906

    CrossRef

  52. 52
    Emily M. Johnson, Meredith E. Coles, Failure and Delay in Treatment-Seeking Across Anxiety Disorders, Community Mental Health Journal, 2013, 49, 6, 668

    CrossRef

  53. 53
    Marianne Destoop, Filip van den Eede, Marc Ansseau, Adelin Albert, Sophie Vanbelle, Annick Mignon, Patricia Slachmuylders, Bernard Sabbe, Prevalence and clinical characteristics of remission during treatment in generalized anxiety, International Journal of Psychiatry in Clinical Practice, 2013, 17, 2, 90

    CrossRef

  54. 54
    J Winner, J D Allen, C Anthony Altar, A Spahic-Mihajlovic, Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression, Translational Psychiatry, 2013, 3, 3, e242

    CrossRef

  55. 55
    Anja Cerne, Janez Rifel, Danica Rotar-Pavlic, Igor Svab, Polona Selic, Janko Kersnik, Quality of life in patients with depression, panic syndrome, other anxiety syndrome, alcoholism and chronic somatic diseases: a longitudinal study in Slovenian primary care patients, Wiener klinische Wochenschrift, 2013, 125, 1-2, 1

    CrossRef

  56. 56
    B. Leuner, T.J. Shors, Stress, anxiety, and dendritic spines: What are the connections?, Neuroscience, 2013, 251, 108

    CrossRef

  57. 57
    Michael Linden, Borwin Bandelow, Reinhard Joachim Boerner, Matthias Brasser, Siegfried Kasper, Hans-Jürgen Möller, Lena Pyrkosch, Hans-Peter Volz, Hans-Ulrich Wittchen, The best next drug in the course of generalized anxiety disorders: the “PN-GAD-algorithm”, International Journal of Psychiatry in Clinical Practice, 2013, 17, 2, 78

    CrossRef

  58. 58
    Ifigeneia Mavranezouli, Nick Meader, John Cape, Tim Kendall, The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder, PharmacoEconomics, 2013, 31, 4, 317

    CrossRef

  59. 59
    L. Boschloo, N. Vogelzangs, W. van den Brink, J. H. Smit, A. T. F. Beekman, B. W. J. H. Penninx, The role of negative emotionality and impulsivity in depressive/anxiety disorders and alcohol dependence, Psychological Medicine, 2013, 43, 06, 1241

    CrossRef

  60. 60
    R. Sandelin, J. Kowalski, E. Ahnemark, C. Allgulander, Treatment patterns and costs in patients with generalised anxiety disorder: One-year retrospective analysis of data from national registers in Sweden, European Psychiatry, 2013, 28, 2, 125

    CrossRef

  61. 61
    Michelle G. Newman, Sandra J. Llera, Thane M. Erickson, Amy Przeworski, Louis G. Castonguay, Worry and Generalized Anxiety Disorder: A Review and Theoretical Synthesis of Evidence on Nature, Etiology, Mechanisms, and Treatment, Annual Review of Clinical Psychology, 2013, 9, 1, 275

    CrossRef

  62. 62
    Sarah A. Hayes-Skelton, Aisha Usmani, Jonathan K. Lee, Lizabeth Roemer, Susan M. Orsillo, A Fresh Look at Potential Mechanisms of Change in Applied Relaxation for Generalized Anxiety Disorder: A Case Series, Cognitive and Behavioral Practice, 2012, 19, 3, 451

    CrossRef

  63. You have free access to this content63
    Ruihua Hou, David S. Baldwin, A neuroimmunological perspective on anxiety disorders, Human Psychopharmacology: Clinical and Experimental, 2012, 27, 1
  64. 64
    Stephanie Booth-Kewley, Robyn M. Highfill-McRoy, Gerald E. Larson, Cedric F. Garland, Thomas A. Gaskin, Anxiety and Depression in Marines Sent to War in Iraq and Afghanistan, The Journal of Nervous and Mental Disease, 2012, 200, 9, 749

    CrossRef

  65. 65
    Lauren E. Edwards, Briana Mezuk, Anxiety and risk of type 2 diabetes: Evidence from the Baltimore Epidemiologic Catchment Area Study, Journal of Psychosomatic Research, 2012, 73, 6, 418

    CrossRef

  66. 66
    Nader Amir, Charles T. Taylor, Combining Computerized Home-Based Treatments for Generalized Anxiety Disorder: An Attention Modification Program and Cognitive Behavioral Therapy, Behavior Therapy, 2012, 43, 3, 546

    CrossRef

  67. 67
    Nina C. Donner, Philip L. Johnson, Stephanie D. Fitz, Karen E. Kellen, Anantha Shekhar, Christopher A. Lowry, ELEVATED tph2 mRNA EXPRESSION IN A RAT MODEL OF CHRONIC ANXIETY, Depression and Anxiety, 2012, 29, 4
  68. 68
    Juan-Antonio Micó, Rita Prieto, Elucidating the Mechanism of Action of Pregabalin, CNS Drugs, 2012, 26, 8, 637

    CrossRef

  69. 69
    Dennis A. Revicki, Karin Travers, Kathleen W. Wyrwich, Henrik Svedsäter, Julie Locklear, Maria Stoeckl Mattera, David V. Sheehan, Stuart Montgomery, Humanistic and economic burden of generalized anxiety disorder in North America and Europe, Journal of Affective Disorders, 2012, 140, 2, 103

    CrossRef

  70. 70
    Courtney Beard, Risa B. Weisberg, Jennifer Primack, Socially Anxious Primary Care Patients’ Attitudes Toward Cognitive Bias Modification (CBM): A Qualitative Study, Behavioural and Cognitive Psychotherapy, 2012, 40, 05, 618

    CrossRef

  71. 71
    Jennifer L. Francis, Ethan Moitra, Ingrid Dyck, Martin B. Keller, THE IMPACT OF STRESSFUL LIFE EVENTS ON RELAPSE OF GENERALIZED ANXIETY DISORDER, Depression and Anxiety, 2012, 29, 5
  72. 72
    Brian Fisak, Alicia C. von Lehe, The Relation Between the Five Facets of Mindfulness and Worry in a Non-clinical Sample, Mindfulness, 2012, 3, 1, 15

    CrossRef

  73. 73
    Alexander Bystritsky, Sarit Hovav, Cathy Sherbourne, Murray B. Stein, Raphael D. Rose, Laura Campbell-Sills, Daniela Golinelli, Greer Sullivan, Michelle G. Craske, Peter P. Roy-Byrne, Use of Complementary and Alternative Medicine in a Large Sample of Anxiety Patients, Psychosomatics, 2012, 53, 3, 266

    CrossRef

  74. 74
    Leszek Bidzan, Atul R. Mahableshwarkar, Paula Jacobsen, Mingjin Yan, David V. Sheehan, Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial, European Neuropsychopharmacology, 2012, 22, 12, 847

    CrossRef

  75. 75
    Rosario B. Hidalgo, David V. Sheehan, Neurobiology of Psychiatric Disorders, 2012,

    CrossRef

  76. 76
    M. E. Palm, R. Elliott, S. McKie, J. F. W. Deakin, I. M. Anderson, Attenuated responses to emotional expressions in women with generalized anxiety disorder, Psychological Medicine, 2011, 41, 05, 1009

    CrossRef

  77. 77
    Courtney Beard, Cognitive bias modification for anxiety: current evidence and future directions, Expert Review of Neurotherapeutics, 2011, 11, 2, 299

    CrossRef

  78. 78
    Julio Bobes, Luis Caballero, Inma Vilardaga, Javier Rejas, Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?, Annals of General Psychiatry, 2011, 10, 1, 7

    CrossRef

  79. 79
    Emilie Chazelle, Cédric Lemogne, Karen Morgan, Cecily C. Kelleher, Jean-François Chastang, Isabelle Niedhammer, Explanations of educational differences in major depression and generalised anxiety disorder in the Irish population, Journal of Affective Disorders, 2011, 134, 1-3, 304

    CrossRef

  80. 80
    Sarah J. Kertz, Janet Woodruff-Borden, Human and Economic Burden of GAD, Subthreshold GAD, and Worry in a Primary Care Sample, Journal of Clinical Psychology in Medical Settings, 2011, 18, 3, 281

    CrossRef

  81. 81
    Juan M. Cabasés, Eduardo Sánchez Iriso, Joan Rovira i Forns, Javier Rejas, La calidad de vida y los costes asociados a la salud de los pacientes con trastorno de ansiedad generalizada: una aproximación bayesiana, PharmacoEconomics Spanish Research Articles, 2011, 8, 1, 3

    CrossRef

  82. 82
    Bojan Lalovic, Matt Hutmacher, Bill Frame, Raymond Miller, Modeling Dropout From Adverse Event Data: Impact of Dosing Regimens Across Pregabalin Trials in the Treatment of Generalized Anxiety Disorder, The Journal of Clinical Pharmacology, 2011, 51, 5
  83. 83
    Martin A. Katzman, Alex Copeland, Larry J. Klassen, Pratap Chokka, Olga Brawman-Mintzer, Pharmacotherapy for Generalized Anxiety Disorder, Psychiatric Annals, 2011, 41, 2, 95

    CrossRef

  84. 84
    Cynthia L. Turk, Douglas S. Mennin, Phenomenology of Generalized Anxiety Disorder, Psychiatric Annals, 2011, 41, 2, 72

    CrossRef

  85. 85
    Blake F. Dear, Nickolai Titov, Matthew Sunderland, Dean McMillan, Tracy Anderson, Carolyn Lorian, Emma Robinson, Psychometric Comparison of the Generalized Anxiety Disorder Scale-7 and the Penn State Worry Questionnaire for Measuring Response during Treatment of Generalised Anxiety Disorder, Cognitive Behaviour Therapy, 2011, 40, 3, 216

    CrossRef

  86. 86
    Susan E. Michelson, Jonathan K. Lee, Susan M. Orsillo, Lizabeth Roemer, The role of values-consistent behavior in generalized anxiety disorder, Depression and Anxiety, 2011, 28, 5
  87. 87
    Jeannette Golden, Ronán M. Conroy, Irene Bruce, Aisling Denihan, Elaine Greene, Michael Kirby, Brian A. Lawlor, The spectrum of worry in the community-dwelling elderly, Aging & Mental Health, 2011, 15, 8, 985

    CrossRef

  88. 88
    Clément François, Nicolas Despiégel, Khaled Maman, Delphine Saragoussi, Pascal Auquier, Anxiety disorders, major depressive disorder and the dynamic relationship between these conditions: treatment patterns and cost analysis, Journal of Medical Economics, 2010, 13, 1, 99

    CrossRef

  89. 89
    M. Brach, C. Sabariego, P. Herschbach, P. Berg, U. Engst-Hastreiter, G. Stucki, Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in chronic arthritis patients, Journal of Public Health, 2010, 32, 4, 547

    CrossRef

  90. 90
    Montserrat Vera-Llonch, Ellen Dukes, Javier Rejas, Oleg Sofrygin, Marko Mychaskiw, Gerry Oster, Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective, The European Journal of Health Economics, 2010, 11, 1, 35

    CrossRef

  91. 91
    Michel J. Dugas, Kristin G. Anderson, Sonya S. Deschenes, Eleanor Donegan, Generalized anxiety disorder publications: Where do we stand a decade later?, Journal of Anxiety Disorders, 2010, 24, 7, 780

    CrossRef

  92. 92
    Andrea Reinecke, Eni S. Becker, Juergen Hoyer, Mike Rinck, Generalized implicit fear associations in Generalized Anxiety Disorder, Depression and Anxiety, 2010, 27, 3
  93. 93
    Courtney Beard, Risa B. Weisberg, Martin B. Keller, Health-related Quality of Life across the anxiety disorders: Findings from a sample of primary care patients, Journal of Anxiety Disorders, 2010, 24, 6, 559

    CrossRef

  94. You have free access to this content94
    Vladimir Coric, Howard H. Feldman, Dan A. Oren, Anantha Shekhar, Joseph Pultz, Randy C. Dockens, Xiaoling Wu, Kimberly A. Gentile, Shu-Pang Huang, Eileen Emison, Terrye Delmonte, Bernadette B. D'Souza, Daniel L. Zimbroff, Jack A. Grebb, Andrew W. Goddard, Elyse G. Stock, Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder, Depression and Anxiety, 2010, 27, 5
  95. 95
    Christian Montag, Ulrike Basten, Christine Stelzel, Christian J. Fiebach, Martin Reuter, The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans, Psychiatry Research, 2010, 179, 1, 86

    CrossRef

  96. 96
    Nickolai Titov, Gavin Andrews, Emma Robinson, Genevieve Schwencke, Luke Johnston, Karen Solley, Isabella Choi, Clinician-assisted Internet-based treatment is effective for generalized anxiety disorder: randomized controlled trial, Australian and New Zealand Journal of Psychiatry, 2009, 43, 10, 905

    CrossRef

  97. 97
    Martin A. Katzman, Current Considerations in the Treatment of Generalized Anxiety Disorder, CNS Drugs, 2009, 23, 2, 103

    CrossRef

  98. 98
    Natalie J. Carter, Paul L. McCormack, Duloxetine, CNS Drugs, 2009, 23, 6, 523

    CrossRef

  99. 99
    Susan G Kornstein, James M Russell, Melissa E Spann, Paul Crits-Christoph, Susan G Ball, Duloxetine in the treatment of generalized anxiety disorder, Expert Review of Neurotherapeutics, 2009, 9, 2, 155

    CrossRef

  100. 100
    Brian M. Ross, Omega-3 polyunsaturated fatty acids and anxiety disorders, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, 81, 5-6, 309

    CrossRef

  101. 101
    Juergen Hoyer, Andrew T. Gloster, Psychotherapy for Generalized Anxiety Disorder: Don't Worry, It Works!, Psychiatric Clinics of North America, 2009, 32, 3, 629

    CrossRef

  102. 102
    Basil G. Bereza, Márcio Machado, Thomas R. Einarson, Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder, Clinical Therapeutics, 2009, 31, 6, 1279

    CrossRef

  103. 103
    C. Montag, B. Weber, K. Fliessbach, C. Elger, M. Reuter, The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression, Psychological Medicine, 2009, 39, 11, 1831

    CrossRef

  104. 104
    Emily K. Porensky, Mary Amanda Dew, Jordan F. Karp, Elizabeth Skidmore, Bruce L. Rollman, M Katherine Shear, Eric J. Lenze, The Burden of Late-Life Generalized Anxiety Disorder: Effects on Disability, Health-Related Quality of Life, and Healthcare Utilization, The American Journal of Geriatric Psychiatry, 2009, 17, 6, 473

    CrossRef

  105. 105
    Gretchen A. Brenes, Mark Knudson, W. Vaughn McCall, Jeff D. Williamson, Michael E. Miller, Melinda A. Stanley, Age and racial differences in the presentation and treatment of Generalized Anxiety Disorder in primary care, Journal of Anxiety Disorders, 2008, 22, 7, 1128

    CrossRef

  106. 106
    Mark H. Pollack, Susan G. Kornstein, Melissa E. Spann, Paul Crits-Christoph, Joel Raskin, James M. Russell, Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint, Journal of Psychiatric Research, 2008, 42, 14, 1176

    CrossRef

  107. 107
    Allison J. Ouimet, Roger Covin, David J. A. Dozois, Generalized Anxiety Disorder, Handbook of Evidence-Based Practice in Clinical Psychology,
  108. 108
    Lauren E. Szkodny, Michelle G. Newman, Generalized Anxiety Disorder, The Wiley Handbook of Cognitive Behavioral Therapy,
  109. 109
    References,